June 10, 2026

Gore secures CE Mark for venous stent to treat inferior vena cava

​Gore has secured CE Mark approval under the MDR for its Gore Viabahn Fortegra venous stent to treat symptomatic IVC...

June 9, 2026

Medtronic secures CE mark for Stealth AXiS system for ENT surgery

​Medtronic has received the CE mark for its Stealth AXiS surgical system, clearing the way for its use in ENT...

June 9, 2026

Coya Therapeutics begins extension phase of ALSTARS trial for COYA 302

​Coya Therapeutics has begun the blinded extension phase of the ALSTARS trial, evaluating the safety and efficacy of COYA 302...

June 9, 2026

Pfizer’s Hympavzi secures FDA expanded indications for haemophilia

​Pfizer has received approval from the FDA for an expanded indication of Hympavzi for the treatment of haemophilia A or...

June 8, 2026

Insulet reports new data for Omnipod 6 and FCL systems

​Insulet has reported results from its STRIVE and EVOLUTION 3 studies, assessing its upcoming Omnipod 6 AID system and a...

June 8, 2026

Novo Nordisk reports Phase II data for zenagamtide in diabetes

​Novo Nordisk has reported results from its Phase II study of zenagamtide, showing drops in blood sugar and body weight...

June 8, 2026

EC grants marketing authorisation for IntraBio’s Aqneursa

​The European Commission (EC) has granted marketing authorisation for IntraBio’s Aqneursa to treat neurological symptoms of NPC.The post EC grants...

June 5, 2026

First patient dosed in Onchilles’ Phase I/II trial of N17350

​Onchilles Pharma has dosed the first patient in its Phase I/II clinical trial of N17350 for patients with advanced solid...

June 5, 2026

FDA approves GE HealthCare’s MIM Contour ProtégéAI+ 2.0 software

​GE HealthCare has received 510(k) clearance from the FDA for its AI-powered MIM Contour ProtégéAI+ 2.0 software.The post FDA approves...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.